PTJ
PRAX icon

Paul Tudor Jones’s Praxis Precision Medicines PRAX Stock Holding History

Paul Tudor Jones’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Sell
1,100
-400
-27% -$127K ﹤0.01% 3002
2026
Q1 		$483K Sell
1,500
-5,500
-79% -$1.7M ﹤0.01% 2845
2025
Q4 		$2.06M Buy
+7,000
New +$1.3M ﹤0.01% 1787

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Paul Tudor Jones's PRAX Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 2,183 shares worth $731K. The stake represents ﹤0.01% of the portfolio and ranks #2614 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in PRAX as recently as Q4 2025.

Paul Tudor Jones first reported a position in PRAX in Q4 2025 and has held it in 2 quarters since. The position peaked at $4.72M in Q4 2025. 307 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Paul Tudor Jones held 2,183 shares of Praxis Precision Medicines worth $731K as of Q2 2026.
  • Praxis Precision Medicines was a new Paul Tudor Jones position in Q2 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2614 holding.
  • Paul Tudor Jones first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 2 quarters since.
  • Paul Tudor Jones's Praxis Precision Medicines position peaked at $4.72M in Q4 2025.
  • 307 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.